The company is collaborating with two UK institutes to assess whether its Signatera ctDNA technology can detect disease recurrence in women treated for breast cancer.
A number of these loci were linked to blood pressure medication targets, and the researchers developed a genetic risk score.
Imperial College London researchers are working on gene drives for mosquitos to fight malaria, NPR reports.
By overlaying epilepsy genetic data onto co-expressed gene networks from post-mortem brain samples, researchers proposed a 320-gene expression network for epilepsy.
The DNA foundries have been funded through an £18 million ($23.5 million) investment from the BBSRC and should all be fully operational by next year.
Using absolute and relative gene expression analyses, researchers identified expression patterns associated with preeclampsia in dozens of placental tissue samples.
Researchers examined virulence, resistance, and transmission patterns in genome sequence data for more than 300 invasive Staphylococcus aureus isolates from Europe.
They will use the funds to develop software tools for designing and testing site-specific CRISPR systems that target drug resistance mechanisms in cancer cells.
Re-sequencing of the Schistosoma mansoni genome provides insight into the parasite's population history.
A University College London-led team has found that microdeletions and microduplications cannot be reliably detected by non-invasive prenatal testing.
A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.
Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.
In Science this week: CRISPR-based approach for recording cellular events, and more.
A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.